Literature DB >> 20716462

The promotion of neurological recovery in the rat spinal cord crushed injury model by collagen-binding BDNF.

Weibang Liang1, Qianqian Han, Wei Jin, Zhifeng Xiao, Jingchun Huang, Hongbin Ni, Bing Chen, Jie Kong, Jun Wu, Jianwu Dai.   

Abstract

Spinal cord crushed injury is clinically common. Promoting targeted neural regeneration at the crushed site of spinal cord could be important for the repair. It has been demonstrated in our previous work that native human BDNF fused with a collagen-binding domain (CBD-BDNF) can bind to collagen specifically to exert the neurotrophic effect on promoting axonal regeneration. After injury, collagen is highly accumulated at the injury site. We thus speculate that CBD-BDNF will bind to the extracellular matrix collagen and concentrate at the injury site to improve the therapy. Using the rat spinal cord crushed injury model, we have found that CBD-BDNF by one-time intrathecally injection could be retained and concentrated at the injury site for a longer time than native BDNF without collagen-binding domain. CBD-BDNF could promote better neural regeneration and locomotion recovery.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716462     DOI: 10.1016/j.biomaterials.2010.07.084

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

1.  Effect of laminin-binding BDNF on induction of recurrent laryngeal nerve regeneration by miR-222 activation of mTOR signal pathway.

Authors:  Jin Xie; Bin Jin; Da-Wei Li; Bin Shen; Ning Gong; Tian-Zhen Zhang; Pin Dong
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  Noninvasive imaging of nanoparticle-labeled transplant populations within polymer matrices for neural cell therapy.

Authors:  Jacqueline A Tickle; Harish Poptani; Arthur Taylor; Divya M Chari
Journal:  Nanomedicine (Lond)       Date:  2018-06       Impact factor: 5.307

Review 3.  The neuronal differentiation microenvironment is essential for spinal cord injury repair.

Authors:  Yannan Zhao; Zhifeng Xiao; Bing Chen; Jianwu Dai
Journal:  Organogenesis       Date:  2017-06-09       Impact factor: 2.500

4.  Tissue-Engineered Regeneration of Hemisected Spinal Cord Using Human Endometrial Stem Cells, Poly ε-Caprolactone Scaffolds, and Crocin as a Neuroprotective Agent.

Authors:  Panieh Terraf; Shideh Montasser Kouhsari; Jafar Ai; Hamideh Babaloo
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

5.  Anti-inflammatory effects of curcumin in experimental spinal cord injury in rats.

Authors:  Wei Jin; Jing Wang; Tiansheng Zhu; Baoyu Yuan; Hongbin Ni; Jian Jiang; Handong Wang; Weibang Liang
Journal:  Inflamm Res       Date:  2014-01-29       Impact factor: 4.575

6.  Netrin-1 attracts axons through FAK-dependent mechanotransduction.

Authors:  Simon W Moore; Xian Zhang; Christopher D Lynch; Michael P Sheetz
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

7.  Curcumin modulates TLR4/NF-κB inflammatory signaling pathway following traumatic spinal cord injury in rats.

Authors:  Hongbin Ni; Wei Jin; Tiansheng Zhu; Jing Wang; Baoyu Yuan; Jian Jiang; Weibang Liang; Zhengliang Ma
Journal:  J Spinal Cord Med       Date:  2014-01-03       Impact factor: 1.985

Review 8.  Biodegradable biomatrices and bridging the injured spinal cord: the corticospinal tract as a proof of principle.

Authors:  Elbert A J Joosten
Journal:  Cell Tissue Res       Date:  2012-03-14       Impact factor: 5.249

9.  Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome?

Authors:  Fábio G Teixeira; Krishna M Panchalingam; Sandra Isabel Anjo; Bruno Manadas; Ricardo Pereira; Nuno Sousa; António J Salgado; Leo A Behie
Journal:  Stem Cell Res Ther       Date:  2015-07-24       Impact factor: 6.832

Review 10.  Regenerative medicine for the treatment of spinal cord injury: more than just promises?

Authors:  Ana Paula Pêgo; Sarka Kubinova; Dasa Cizkova; Ivo Vanicky; Fernando Milhazes Mar; Mónica Mendes Sousa; Eva Sykova
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.